Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
World Sickle Cell Day – June 19, 2018 - The Pharma Times | Pharma & Health Care News Portal
Uncategorized

World Sickle Cell Day – June 19, 2018

  • Gleneagles Global Hospital recommends – Awareness, Education and Hope are the best ways to tackle the Sickle Cell fatality

Hyderabad, June 21, 2018: World Sickle Cell Day is celebrated across world on June 19, 2018. The Sickle Cell Day was established by the United Nations General Assembly in 2008 in order to increase the awareness about the sickle cell disease and its cure among the common public

Sickle Cell disease is an inheritable, genetic and fatal disease causing red blood cells disorders which has been classified as sickle cell anaemia and may lead to death. It is the most common public health problem in the African and Asian countries of the world. Sickle cell disease is a disease in which the hemoglobin in one’s blood clumps together, causing red blood cells to become abnormally shaped. While healthy blood cells are normally round, in someone with this disease, they are C-shaped, like a sickle, and don’t flow properly.

Dr Surekha Devi A, HOD & Specialist for Haematology and Transfusion Department at Gleneagles Global Hospitals says, “Sickle cells are sticky and block blood flow in vessels, which not only puts patients at risk of stroke, it causes intense pain. Still, there has been so little research on sickle cell disease that it is difficult even to write evidence-based protocols. The hallmark of the disease is what are called painful vaso-occlusive crisis, where patients have significant bone pain requiring hospitalization and a lot of pain medications. There has been improvement is treatments. As recently as 30 years ago, the average lifespan for people with sickle cell disease was only 14 years. Today, life expectancy can reach 42 and beyond.”

We’ve made strides in the last 20 years, particularly with a drug called hydroxyurea,” she says.

“The medication increases production of fetal hemoglobin, which reduces the chance that red blood cells will morph into sickles. While it doesn’t work for everyone, in some, it can reduce hospitalizations. By taking this medication on a daily basis, we can ameliorate the patient for certain period,” Dr Sukehha Devi said, “and in some patients, they simply stop having these painful episodes.”

Dr Surekha Devi A of Gleneagles Global Hospital detected that early screening might safeguard the patients from suffering from permanent kidney damage, stroke or other chronic conditions due to delayed diagnosis and in turn, delayed medical intervention.

Sickle cells die quickly, which causes the constant shortage of red blood cells known as ‘Anemia’. While that aspect of the disease leaves patients feeling exhausted, for many, the most difficult part is the episodes of debilitating discomfort.

Sickle cell disease has become a common and foremost genetic disease worldwide which can be cured through the fast awareness campaign, curable activities, early diagnosis and management.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

13 hours ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

3 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

1 week ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

2 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago